Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2012
03/28/2012EP1283851B1 Use of il-4r antibodies and compositions thereof
03/28/2012EP1283716B1 Vaccine comprising a tick cement protein
03/28/2012EP1181318B2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
03/28/2012EP1098909B1 Hybrid human/rodent igg antibody to cd3, and methods of its construction
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN102395887A Immunoassay for the detection of procalcitonin
03/28/2012CN102395604A Humanised antibodies with anti-tumour activity
03/28/2012CN102395603A Diagnosis and treatment of cancer using anti-lgr7 antibody
03/28/2012CN102395602A B-lymphocyte targeting agents for use in a method for the treatment of a disease
03/28/2012CN102395597A Methods of purifying small modular immunopharmaceutical proteins
03/28/2012CN102392019A Novel oxidoreductases and uses thereof
03/28/2012CN102391994A Monoclonal antibody and hybridoma cell line secreting monoclonal antibody
03/28/2012CN102391993A Hybridoma cell strain 17C8 and monoclonal antibody generated therefrom used in Brucella detection
03/28/2012CN102391992A Monoclonal antibody for resisting human NSCLC and application of monoclonal antibody
03/28/2012CN102391375A Method for producing antibody by coupling multi-polypeptide epitope of protein antigen with carrier
03/28/2012CN102391198A Melamine caproic acid and preparation method and use thereof
03/28/2012CN102389574A Application of ITPKA (inositol-trisphosphate 3-kinase A) gene and expression protein thereof in preparing and screening anti-cancer medicament
03/28/2012CN101942416B Anti-human cardiac troponin I specific monoclonal antibody and preparation method thereof
03/28/2012CN101747425B Protein relevant to retina photoreaction as well as coding gene and applications thereof
03/27/2012US8143385 Nucleic acids coding for antibodies against human IL-21 receptor and uses therefor
03/27/2012US8143380 Protein fusions comprising immunoglobulin regions exhibiting improved bioefficacy in multidose administration for use in treatment of infection, cell proliferative, autoimmune and inflammatory disorders
03/27/2012US8143379 Human monoclonal antibodies to CTLA-4
03/27/2012US8143218 Treatment of skin, and wound repair, with thymosin beta 4
03/27/2012US8143058 Human CDR-grafted antibody and antibody fragment thereof
03/27/2012US8143056 Vascular adhesion molecules and modulation of their function
03/27/2012US8142998 Osteoarthritis biomarkers and uses thereof
03/27/2012US8142791 Multi-modal cancer therapy using viral hitch-hiking
03/27/2012US8142790 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
03/27/2012US8142789 Method for selecting and producing vaccine components and vaccines based thereon
03/27/2012US8142784 Antibody-drug conjugates and methods
03/27/2012US8142780 Anti-bacterial antibodies
03/27/2012US8142778 Methods of treatment using CTLA-4 antibodies
03/27/2012US8142777 Monoclonal antibody specific to colon stimulating factor for use in treatment and prevention of rheumatoid arthritis
03/27/2012US8142773 Isolating progenitor cell tissue via antibody specific binding, transfering into recipient host, monitor cell propagation; tissue engineering; regenerative medicine
03/27/2012CA2554968C Process for screening glycoform-specific antibodies
03/27/2012CA2501818C Pharmaceutical compositions directed to erb-b1 receptors
03/27/2012CA2467633C Antibody categorization based on binding characteristics
03/27/2012CA2407423C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
03/27/2012CA2309903C Nucleic acid sequences encoding capsaicin receptor
03/27/2012CA2287545C Ma family polypeptides and anti-ma antibodies
03/27/2012CA2245496C Receptor protein designated 2f1
03/27/2012CA2230029C Multi-subtype fiv vaccines
03/22/2012WO2012037196A1 Methods of treating autoimmune diseases with anti-fceri antibodies
03/22/2012WO2012036870A2 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
03/22/2012WO2012036392A2 Human anti-epidermal growth factor receptor fab antibody and a pharmaceutical composition for treating tumours comprising the same
03/22/2012WO2012036094A1 Lung cancer identification marker
03/22/2012WO2012035518A1 Compositions and methods for treatment of drug resistant multiple myeloma
03/22/2012WO2012035141A1 Anti-hutnfr1 antibody
03/22/2012WO2012035088A1 Na+/Mg2+ exchanger
03/22/2012WO2012009631A8 Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods
03/22/2012WO2012006341A3 Anti-ron antibodies
03/22/2012WO2010112458A8 Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betal subunit
03/22/2012US20120073004 Hybrid Light Chain Mice
03/22/2012US20120073002 Prevention and treatment of blood coagulation-related disases
03/22/2012US20120071637 Selective enrichment of antibodies
03/22/2012US20120071636 Risperidone immunoassay
03/22/2012US20120071635 Methods and compositions for modulating tumor cell activity
03/22/2012US20120071634 Antibody Constant Region Variant
03/22/2012US20120071633 Method for purification of target polypeptides
03/22/2012US20120071632 Lenalidomide and Thalidomide Immunoassays
03/22/2012US20120070875 Amino Acid Sequences which Enhance Peptide Conjugate Solubility
03/22/2012US20120070851 Antibody specific to methicillin resistant staphylococcus aureus, detection method and kit for methicillin resistant staphylococcus aureus using the same
03/22/2012US20120070847 Method For Detecting And Purifying Pancreatic Beta Cells
03/22/2012US20120070845 Methods, systems and reagents for improved immunodetection
03/22/2012US20120070827 Detection of fetal cells from maternal blood
03/22/2012US20120070460 Dendritic cell modulatory molecule
03/22/2012US20120070457 Polypeptides from neisseria meningitidis
03/22/2012US20120070454 Dengue vaccine, pharmaceutical composition comprising the same, nucleotide sequence and antibody composition
03/22/2012US20120070450 Leukemia stem cell markers
03/22/2012US20120070448 Anti-il-3ra antibody for use in treatment of blood tumor
03/22/2012US20120070447 Methods of administering / dosing anti-rsv antibodies for prophylaxis and treatment
03/22/2012US20120070446 Rsv specific binding molecule
03/22/2012US20120070444 IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
03/22/2012US20120070443 Pde1 as a target therapeutic in heart disease
03/22/2012US20120070440 Therapeutic use of anti-cs1 antibodies
03/22/2012US20120070439 Antigen-binding proteins
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070435 Chimeric antigens for eliciting an immune response
03/22/2012US20120070430 Identification of tumor-associated markers for diagnosis and therapy
03/22/2012US20120070426 Peptide-based passive immunization therapy for the treatment of atherosclerosis
03/22/2012US20120070406 Therapeutic protein compositions having reduced immunogenicity and/or improved efficacy
03/22/2012US20120070377 Compounds and biological materials and uses thereof
03/22/2012CA2811538A1 Na+/mg2+ exchanger
03/22/2012CA2810465A1 Anti-hutnfr1 antibody
03/22/2012CA2810390A1 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
03/21/2012EP2431463A1 Test agent for visceral obesity and use thereof
03/21/2012EP2431393A1 Anti-axl antibody
03/21/2012EP2431392A1 Antibodies against human IL-22 and uses therefor
03/21/2012EP2431391A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
03/21/2012EP2431381A2 Synthetic oligopeptides designed from mite cysteine proteases and methods for the production of igy polyclonal antibodies for the detection of intradomiciliary mites
03/21/2012EP2431054A2 Human tumor necrosis factor delta and epsilon
03/21/2012EP2431053A1 Novel glycosylated peptide target in neoplastic cells
03/21/2012EP2431050A1 Methods of treating cancer using IL-21 and monoclonal antibody therapy
03/21/2012EP2430157A1 Antigen peptide and use thereof
03/21/2012EP2430156A1 Modified fluorescent proteins and methods for using same
03/21/2012EP2430153A1 Methods of using immunoglobulin aggregates
03/21/2012EP2430051A1 Compositions containing antibodies for treating cd5+ hla-dr+ b or t cell related diseases
03/21/2012EP2430050A1 Humanized axl antibodies
03/21/2012EP2430049A1 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
03/21/2012EP2430048A1 Blocking anti-dkk-1 antibodies and their uses
1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 1494